Designing drug trials for Alzheimer’s disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force
Vellas, Bruno, Carrillo, Maria C., Sampaio, Cristina, Brashear, H. Robert, Siemers, Eric, Hampel, Harald, Schneider, Lon S., Weiner, Michael, Doody, Rachelle, Khachaturian, Zaven, Cedarbaum, Jesse, GrVolume:
9
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2013.03.007
Date:
July, 2013
File:
PDF, 625 KB
english, 2013